Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Operating activities
Net increase (decrease) in net assets resulting from operations	$ 22,713,879	$ 12,448,960
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss	30,629,704	78,534
Change in net unrealized (appreciation) depreciation of investments	(28,144,938)	7,291,773
Net amortization of investment discounts and premiums	(1,929,048)	(3,070,677)
Amortization of original issue discount on debt	52,055	48,211
Interest and dividend income paid in kind	(1,584,834)	(1,080,205)
Amortization of deferred debt issuance costs	712,804	833,279
Changes in assets and liabilities:
Purchases of investments	(74,436,852)	(111,273,535)
Proceeds from disposition of investments	19,323,506	153,441,388
Decrease (increase) in interest, dividends and fees receivable	(1,485,291)	(1,397,414)
Decrease (increase) in receivable for investments sold	0	5,790,508
Decrease (increase) in prepaid expenses and other assets	238,302	(660,293)
Increase (decrease) in payable for investments purchased	(1,937,465)	(28,994,390)
Increase (decrease) in incentive fees payable	506,121	447,787
Increase (decrease) in interest and debt related payables	(5,219,188)	(7,654,248)
Increase (decrease) in reimbursements due to the Advisor	940,571	114,757
Increase (decrease) in management fees payable	(473,480)	84,534
Increase (decrease) in accrued expenses and other liabilities	(321,615)	231,424
Net cash provided by (used in) operating activities	(40,415,769)	26,680,393
Financing activities
Draws on credit facilities	117,884,208	314,017,741
Repayments of credit facility draws	(39,741,067)	(159,268,836)
Dividends paid to shareholders	(21,373,887)	(17,330,179)
Repayment of convertible notes	0	(140,000,000)
Net cash provided by (used in) financing activities	56,769,254	(2,581,274)
Net increase (decrease) in cash and cash equivalents (including restricted cash)	16,353,485	24,099,119
Cash and cash equivalents (including restricted cash) at beginning of period	82,435,171	19,552,273	$ 19,552,273
Cash and cash equivalents (including restricted cash) at end of period	98,788,656	43,651,392	$ 82,435,171
Supplemental cash flow information
Interest payments	15,793,455	15,859,911
Excise tax payments	$ 35,440	$ 0